# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY AND INSTRUMENT COMBINATION TEMPLATE

A. 510(k) Number: k092686   
B. Purpose for Submission: New Device

C. Measurand: pH, pCO2, pO2, Potassium, Sodium, Calcium, Chloride, Glucose, Lactate, Hemoglobin, sO2, FO2Hb, FCOHb, FMetHb, FHHb and FHbF

D. Type of Test: Quantitative - Sensors using Potentiometry, Amperometry, Optical pO2 and Spectrophotometry

E. Applicant: Radiometer Medical Aps

F. Proprietary and Established Names: ABL90 FLEX

# G. Regulatory Information:

1. Regulation section: 21CFR 862.1600: Potassium test system. 21CFR 862.1345: Glucose test system. 21CFR 862.1170: Chloride test system. 21CFR 864.7425: Carboxyhemoglobin assay. 21CFR 864.5620: Automated hemoglobin system. 21CFR 862.1145: Calcium test system. 21CFR 862.1665: Sodium test system. 21CFR 862.1150: Calibrator. 21CFR 864.7455: Fetal hemoglobin assay. 21CFR 862.1660: Quality control material (assayed and unassayed). 21CFR 862.1450: Lactic acid test system.

2. Classification: II, II, II, II, II, II, II, II, II, I (reserved), I (limitation to exemption per 21 CFR 862.9 (c)(9)), respectively

3. Product code:

CEM - ELECTRODE, ION SPECIFIC, POTASSIUM CGA - GLUCOSE OXIDASE, GLUCOSE

CGZ - ELECTRODE, ION-SPECIFIC, CHLORIDE  
GHS - ASSAY, CARBOXYHEMOGLOBIN  
GKR - SYSTEM, HEMOGLOBIN, AUTOMATED  
JFP - ELECTRODE, ION SPECIFIC, CALCIUM  
JGS - ELECTRODE, ION SPECIFIC, SODIUM  
JIX - CALIBRATOR, MULTI-ANALYTE MIXTURE  
KQI - ASSAY, FETAL HEMOGLOBIN  
JJY - MULTI-ANALYTE CONTROLS, ALL KINDS (ASSAYED ANDUNASSAYED)  
KHP - ACID, LACTIC, ENZYMATIC METHOD

4. Panel: Clinical Chemistry (75) and Hematology (81)

# H. Intended Use:

1. Intended use(s): See Indication(s) for use below

2. Indication(s) for use:

The ABL90 FLEX is a portable, automated analyzer that measures $\mathsf { p H }$ , blood gases, electrolytes, glucose, lactate and oximetry in heparinized whole blood. The ABL90 FLEX is intended for use by trained technologists, nurses, physicians and therapists. It is intended for use in a laboratory environment, near patient or pointof-care setting.

These tests are only performed under a physician's order:

pH, pO2 and $\mathtt { p C O 2 } : \mathtt { p H }$ , pCO2 and pO2 measurements are used in the diagnosis and treatment of life-threatening acid-base disturbances.

Potassium $\left( \mathrm { c K ^ { + } } \right)$ : potassium measurements are used to monitor electrolyte balance in the diagnosis and treatment of disease conditions characterized by low or high blood potassium levels.

Sodium $\left( \mathrm { c N a + } \right)$ : sodium measurements are used in the diagnosis and treatment of aldosteronism, diabetes insipidus, adrenal hypertension, Addison's disease, dehydration, inappropriate antidiuretic secretion, or other diseases involving electrolyte imbalance.

Calcium $( \mathsf { c } \mathsf { C } \mathsf { a } 2 + )$ : calcium measurements are used in the diagnosis and treatment of parathyroid disease, a variety of bone diseases, chronic renal disease and tetany.

Chloride (cCl-): chloride measurements are used in the diagnosis and treatment of electrolyte and metabolic disorders such a cystic fibrosis and diabetic acidosis.

Glucose (cGlu): glucose measurements are used in the diagnosis and treatment of carbohydrate metabolism disorders including diabetes mellitus and idiopathic hypoglycemia, and of pancreatic islet cell carcinoma.

Lactate (cLac): The lactate measurements measure the concentration of lactate in plasma. Lactate measurements are used to evaluate the acid-base status and are used in the diagnosis and treatment of lactic acidosis (abnormally high acidity of the blood.)

Total Hemoglobin (ctHb): total hemoglobin measurements are used to measure the hemoglobin content of whole blood for the detection of anemia.

sO2: oxygen saturation, more specifically the ratio between the concentration of oxyhemoglobin and oxyhemoglobin plus reduced hemoglobin.

FO2Hb: oxyhemoglobin as a fraction of total hemoglobin.

FCOHb: carboxyhemoglobin measurements are used to determine the carboxyhemoglobin content of human blood as an aid in the diagnosis of carbon monoxide poisoning.

FMetHb: methemoglobin as a fraction of total hemoglobin.

FHHb: reduced hemoglobin as a fraction of total hemoglobin.

Fraction of Fetal Hemoglobin (FHbF): FHbF indicates the amount of fetal hemoglobin. FHbF is seldom used clinically.

3. Special conditions for use statement(s): Prescription use

4. Special instrument requirements: ABL90 FLEX analyzer

# I. Device Description:

The ABL90 FLEX system consists of a modular analyzer incorporating a user interface module with a large color touch screen interfacing the analyzer electronic and fluidic modules. The user interface module contains the analyzer CPU and all of the required electronic interfaces for external communication and data storage.

Sensors that measure pH, pO2, pCO2, potassium, sodium, calcium, chloride, glucose and lactate are contained in a sensor cassette that connects to the sample inlet. This cassette attaches to the front of the instrument. An oximetry module measures ctHb, sO2, FO2Hb, FCOHb, FMetHb and FHHb. This module consists of a spectrometer, an ultrasonic hemolyzer and thermostatic components integrated into the instrument.

The system also includes a solution pack for the calibration and automatic quality control of the sensor and oximetry system. The solution pack includes calibration and quality control reagents individually packaged in sealed foil pouches.

# J. Substantial Equivalence Information:

1. Predicate device name(s): Radiometer’s ABL80 FLEX CO-OX (k080370), ABL800/700 (k002290, k041874, k050869), NPT7 (k982928)

2. Predicate 510(k) number(s): See predicate device names above

3. Comparison with predicate:

<table><tr><td colspan="3" rowspan="1">Similarities</td></tr><tr><td colspan="3" rowspan="1">Item                Device                                       Predicate Device</td></tr><tr><td colspan="3" rowspan="1">ABL90 FLEX                               ABL80 FLEX CO-OX (k080370)</td></tr><tr><td colspan="1" rowspan="1">Intendeduse/Indicationsfor use</td><td colspan="1" rowspan="1">A portable, automated analyzer thatmeasures multiple analytes inheparinized whole blood. It is intendedfor use by trained technologists, nurses,physicians and therapists. It is intendedfor use in a laboratory environment, nearpatient or point-of-care setting.</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Blood GasMeasurement</td><td colspan="1" rowspan="1">pH and pCO2 by potentiometry</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">ElectrolyteMeasurement</td><td colspan="1" rowspan="1">cK+, cNa+, cCa2+, cCl- bypotentiometry</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">MetaboliteMeasurement</td><td colspan="1" rowspan="1">cGlu by amperometry</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">OximetryMeasurement</td><td colspan="1" rowspan="1">Contains spectrophotometer foroximetry</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">SensorTechnology</td><td colspan="1" rowspan="1">Potentiometric and amperometricsensors on a single substrate micro-electrode array</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Sampleintroduction</td><td colspan="1" rowspan="1">Aspiration</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">In-use-life ofconsumables</td><td colspan="1" rowspan="1">Up to a maximum of 30 days</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">CalibrationMethod</td><td colspan="1" rowspan="1">Two-Point liquid calibration</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Calibration andQC reagents</td><td colspan="1" rowspan="1">Calibration and QC reagents plus awaste reservoir are contained in onesolution pack</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Calibration andQC reagents</td><td colspan="2" rowspan="1">"Smartchip "technology for uniqueidentification and lot specific calibrationand quality control data</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">User interface</td><td colspan="2" rowspan="1">Menu driven touch screen</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Other analyzerhardware</td><td colspan="2" rowspan="1">Hard drive and printer</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Softwareoperating system</td><td colspan="2" rowspan="1">Microsoft XPe</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="4" rowspan="1">Item               ABL90 FLEX                             ABL800/700(k002290, k041874,K50869</td></tr><tr><td colspan="1" rowspan="1">Blood GasMeasurement</td><td colspan="2" rowspan="1">pH and pCO2 by potentiometry</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">ElectrolyteMeasurement</td><td colspan="2" rowspan="1">cK+ ,cNa+ ,cCa2+ ,cCl- bypotentiometry</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">MetaboliteMeasurement</td><td colspan="2" rowspan="1">cGlu, cLac by amperometry</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">OximetryMeasurement</td><td colspan="2" rowspan="1">ctHb ,sO2, FO2Hb, FHHb, FCOHb,FMetHb, FHbF,</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Hemoglobinmeasurement</td><td colspan="2" rowspan="1">Spectrophotometry</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">CalibrationMethod</td><td colspan="2" rowspan="1">Two-Point liquid calibration</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">User interface</td><td colspan="2" rowspan="1">Menu driven touch screen</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Other analyzerhardware</td><td colspan="2" rowspan="1">Hard drive and printer</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Softwareoperating system,data management</td><td colspan="2" rowspan="1">Microsoft XPe</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Item</td><td colspan="2" rowspan="1">ABL90 FLEX</td><td colspan="1" rowspan="1">ABL800 (k050869)</td></tr><tr><td colspan="1" rowspan="1">Samplepreparation</td><td colspan="2" rowspan="1">Built-in sample mixer</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Item</td><td colspan="2" rowspan="1">ABL90 FLEX</td><td colspan="1" rowspan="1">NPT7 (K982928)</td></tr><tr><td colspan="1" rowspan="1">Blood GasMeasurement</td><td colspan="2" rowspan="1">p02 optical</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">ctHb, sO2,FO2Hb</td><td colspan="2" rowspan="1">Spectrophotometry</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Calibration</td><td colspan="2" rowspan="1">Atmospheric air</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="4" rowspan="1">Differences</td></tr><tr><td colspan="4" rowspan="1">Item              ABL90 FLEX              ABL80 FLEX CO-OX (k080370)</td></tr><tr><td colspan="1" rowspan="1">Sample volume</td><td colspan="1" rowspan="1">65 micro liters</td><td colspan="2" rowspan="1">100 micro liters</td></tr><tr><td colspan="1" rowspan="1">Solution Pack</td><td colspan="1" rowspan="1">Contains a pouch withlow pressure gas forquality control of oxygensensor</td><td colspan="2" rowspan="1">No gas pouch</td></tr><tr><td colspan="1" rowspan="1">Storageconditions ofSensor Cassette</td><td colspan="1" rowspan="1">2°C-8°C w/ up to twoweeks at 32°</td><td colspan="2" rowspan="1">5°C-25°C w/ up to two weeks at32</td></tr><tr><td colspan="1" rowspan="1">Storageconditions for theSolution Pack</td><td colspan="1" rowspan="1">2°C-25°C w/ up to twoweeks at 32°</td><td colspan="2" rowspan="1">12-25°C with up to two weeks, at32</td></tr><tr><td colspan="1" rowspan="2">Analyzeroperatingtemperature</td><td colspan="1" rowspan="2">15-32°</td><td></td></tr><tr><td colspan="1" rowspan="1">12-28°</td></tr><tr><td colspan="1" rowspan="1">Software, wetsection control</td><td colspan="1" rowspan="1">Independently designed</td><td colspan="1" rowspan="1">Independently designed</td></tr><tr><td colspan="3" rowspan="1">Item                ABL90 FLEX              ABL800/700 (k002290, k041874,k050869)</td></tr><tr><td colspan="1" rowspan="1">Oximetrysystem</td><td colspan="1" rowspan="1">Contains oximetry systembased on a 256-wavelengthspectrophotometer with ameasuring range of 467-672 nm</td><td colspan="1" rowspan="1">Oximetry module is based on a 128-wavelength spectrophotometer with ameasuring range of 478-672nm</td></tr><tr><td colspan="1" rowspan="1">Sensors</td><td colspan="1" rowspan="1">The amperometricsensors for glucose andlactate and thepotentiometric sensors forpH, cNa+, cK+, cCa2+,cCl-, pCO2 in adisposable sensor cassette</td><td colspan="1" rowspan="1">Traditional, discrete amperometricand potentiometric sensors installedin the analyzer</td></tr><tr><td colspan="1" rowspan="1">Calibration andQC solutions</td><td colspan="1" rowspan="1">Calibration and QCsolutions, plus a wastereservoir are contained inone solution pack</td><td colspan="1" rowspan="1">Discrete bottles and ampoules</td></tr><tr><td colspan="1" rowspan="1">Sample volume</td><td colspan="1" rowspan="1">65 micro liters</td><td colspan="1" rowspan="1">195 microliters</td></tr><tr><td colspan="1" rowspan="1">Software, wetsection control</td><td colspan="1" rowspan="1">Independently designed</td><td colspan="1" rowspan="1">Independently designed</td></tr><tr><td colspan="3" rowspan="1">Item               ABL90 FLEX              NPT7 (k982928)</td></tr><tr><td colspan="1" rowspan="1">Sensortechnology</td><td colspan="1" rowspan="1">pH, pCO2 bypotentiometry</td><td colspan="1" rowspan="1">pH, pCO2 by optical sensors</td></tr><tr><td colspan="1" rowspan="1">Sensor cassette</td><td colspan="1" rowspan="1">Multiple measurementsup to 900 specimens</td><td colspan="1" rowspan="1">30 test cartridges, each for onespecimen only</td></tr><tr><td colspan="1" rowspan="1">Calibrants</td><td colspan="1" rowspan="1">Liquid calibrants andatmospheric air</td><td colspan="1" rowspan="1">Atmospheric air as solecalibrant/calibration verificationcompound</td></tr><tr><td colspan="1" rowspan="1">Analyzerhardware andsoftware</td><td colspan="1" rowspan="1">Independently designed</td><td colspan="1" rowspan="1">Independently designed</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

CLSI - Evaluation of Precision Performance of Clinical Chemistry Devices - EP05- A2   
CLSI - Evaluation of the Linearity of Quantitative Analytical Methods - EP06-A   
CLSI - Interference Testing in Clinical Chemistry - EP07-A2   
CLSI - Method Comparison and Bias Estimation Using Patient Samples - EP09-A2   
CLSI - Protocols for Determination of Limits of Detection and Limits of Quantitation - EP17-A

# L. Test Principle:

There are four different measuring principles employed in the sensors in the ABL90 FLEX analyzer.

Potentiometry: The potential of a sensor chain is recorded using a voltmeter, and related to the concentration of the sample (the Nernst equation). The potentiometric measuring principle is applied in the pH, pCO2, $\mathrm { K } +$ , $\mathrm { N a + }$ , $\mathrm { C a 2 + }$ and Cl- sensors. Amperometry: The magnitude of an electrical current flowing through a sensor chain is proportional to the concentration of the substance being oxidized or reduced at an electrode in the chain. The Amperometric measuring principle is applied in the cGlu and cLac sensors. • Optical pO2: The optical system for pO2 is based on the ability of O2 to reduce the intensity and time constant of the phosphorescence from a phosphorescent dye that is in contact with the sample. This measuring principle is applied in the pO2 sensor. Spectrophotometry: Light passes through a cuvette containing a hemolyzed blood sample. The specific wavelengths absorbed and their intensity generates an absorption spectrum used to calculate oximetry parameters. This measuring principle is used for measuring ctHb, sO2, FO2Hb, FCOHb, FHHb, FMetHb, and FHbF

# M. Performance Characteristics (if/when applicable):

1. Analytical performance: a. Precision/Reproducibility:

Study design A Point-of-care (POC) precision study was performed using NCCLS "Evaluation of Precision Performance of Quantitative Measurement Methods; Approved Guideline - Second Edition", NCCLS EP5-A2, 2004 as guidance.

The study was performed at 3 POC sites. Each site used one ABL90FLEX for precision evaluation of syringe mode, one ABL90FLEX for precision evaluation of capillary mode and one ABL735 for reference purposes.

The test material was prepared samples of heparinized whole blood. Samples for all parameters were prepared to simulate high, medium and low physiological levels. In each study multiple POC staff members performed sample handling and sample transfer.

Each study ran over 20 test days. On each test day, each parameter and level were tested in duplicate per run, two runs per day. The testing was performed in both syringe and capillary mode.

Results

In the tables below Sr is estimate of repeatability and ST is estimate of precision as defined in NCCLS EP5-A2. Low fractions of low hemoglobin are not calculated for $\%$ CV.

ABL90 FLEX Precision - Syringe Study - Pooled Data from 3 Sites   

<table><tr><td>Low level</td><td>pH</td><td>pCO2</td><td>pO2</td><td>Ca</td><td>Cl</td><td>K*</td></tr><tr><td>Unit</td><td></td><td>mmHg</td><td>mmHg</td><td>mEq/L</td><td>mEq/L</td><td>mEq/L</td></tr><tr><td>Mean</td><td>7.272</td><td>28</td><td>44.5</td><td>1.15</td><td>94</td><td>-</td></tr><tr><td>Sr</td><td>0.0019</td><td>0.55</td><td>0.21</td><td>0.006</td><td>0.21</td><td>-</td></tr><tr><td>ST</td><td>0.0037</td><td>0.67</td><td>0.68</td><td>0.035</td><td>1.08</td><td>-</td></tr><tr><td>%CV</td><td>-</td><td>2.4</td><td>1.5</td><td>3.1</td><td>1.2</td><td>-</td></tr><tr><td>N</td><td>240</td><td>240</td><td>240</td><td>240</td><td>240</td><td>-</td></tr><tr><td>Low level</td><td>Na</td><td>Glu</td><td>Lac*</td><td>tHb</td><td>sO2</td><td>COHb</td></tr><tr><td>Unit</td><td>mEq/L</td><td>mg/dL</td><td>mg/dL</td><td>g/dL</td><td>%</td><td>%</td></tr><tr><td>Mean</td><td>119</td><td>13.2</td><td>-</td><td>3.8</td><td>75.1</td><td>-</td></tr><tr><td>Sr</td><td>0.3</td><td>0.52</td><td>-</td><td>0.06</td><td>0.24</td><td>-</td></tr><tr><td>ST</td><td>0.6</td><td>1.16</td><td></td><td>0.09</td><td>0.38</td><td>-</td></tr><tr><td>%CV</td><td>0.5</td><td>8.8</td><td>-</td><td>2.2</td><td>0.5</td><td>-</td></tr><tr><td>N</td><td>240</td><td>240</td><td>-</td><td>240</td><td>240</td><td></td></tr><tr><td>Low level</td><td>MetHb</td><td>HHb</td><td>O2Hb</td><td>HbF</td><td></td><td></td></tr><tr><td>Unit</td><td>%</td><td>%</td><td>%</td><td>%</td><td></td><td></td></tr><tr><td>Mean</td><td>-</td><td>-</td><td>72.4</td><td>-</td><td></td><td></td></tr><tr><td>Sr</td><td>-</td><td>-</td><td>0.23</td><td>-</td><td></td><td></td></tr><tr><td>ST</td><td>-</td><td></td><td>0.46</td><td></td><td></td><td></td></tr><tr><td>%CV</td><td>-</td><td></td><td>0.6</td><td>-</td><td></td><td></td></tr><tr><td>N</td><td>-</td><td>-</td><td>240</td><td>-</td><td></td><td></td></tr><tr><td>Medium level</td><td>pH</td><td>pCO2</td><td>pO2</td><td>Ca</td><td>Cl</td><td>K</td></tr><tr><td>Unit</td><td></td><td>mmHg</td><td>mmHg</td><td>mEq/L</td><td>mEq/L</td><td>mEq/L</td></tr><tr><td>Mean</td><td>7.37</td><td>41.6</td><td>76.1</td><td>2.42</td><td>108</td><td>4.75</td></tr><tr><td>Sr</td><td>0.0012</td><td>0.64</td><td>0.7</td><td>0.013</td><td>0.35</td><td>0.034</td></tr><tr><td>ST</td><td>0.0034</td><td>0.86</td><td>1.12</td><td>0.042</td><td>1.42</td><td>0.065</td></tr><tr><td>%CV</td><td>-</td><td>2.1</td><td>1.5</td><td>1.7</td><td>1.3</td><td>1.4</td></tr><tr><td>N</td><td>240</td><td>240</td><td>240</td><td>240</td><td>240</td><td>240</td></tr><tr><td>Medium level</td><td>Na</td><td>Glu</td><td>Lac</td><td>tHb</td><td>sO2</td><td>COHb</td></tr><tr><td>Unit</td><td>mEq/L</td><td>mg/dL</td><td>mg/dL</td><td>g/dL</td><td>%</td><td>%</td></tr><tr><td>Mean</td><td>141</td><td>98.3</td><td>19.1</td><td>15</td><td>93.1</td><td>3.2</td></tr><tr><td>Sr</td><td>0.4</td><td>0.72</td><td>0.51</td><td>0.09</td><td>0.14</td><td>0.05</td></tr><tr><td>ST</td><td>0.7</td><td>3.18</td><td>1.2</td><td>0.13</td><td>0.034</td><td>0.21</td></tr><tr><td>%CV</td><td>0.5</td><td>3.2</td><td>6.3</td><td>0.9</td><td>0.4</td><td>6.6</td></tr><tr><td>N</td><td>240</td><td>240</td><td>240</td><td>240</td><td>240</td><td>240</td></tr><tr><td>Medium level</td><td>MetHb</td><td>HHb</td><td>O2Hb</td><td>HbF</td><td></td><td></td></tr><tr><td>Unit</td><td>%</td><td>%</td><td>%</td><td>%</td><td></td><td></td></tr><tr><td>Mean</td><td>3.4</td><td>6.7</td><td>90.5</td><td>40.7</td><td></td><td></td></tr><tr><td>Sr</td><td>0.07</td><td>0.14</td><td>0.27</td><td>1.93</td><td></td><td></td></tr><tr><td>ST</td><td>0.17</td><td>0.31</td><td>0.35</td><td>4.98</td><td></td><td></td></tr><tr><td>%CV N</td><td>5 240</td><td>4.6 240</td><td>0.4 236</td><td>12.2 236</td><td></td><td></td></tr><tr><td>High level</td><td>pH</td><td>pCO2</td><td>pO2</td><td>Ca</td><td>Cl</td><td>K</td></tr><tr><td>Unit</td><td></td><td>mmHg</td><td>mmHg</td><td>mEq/L</td><td>mEq/L</td><td>mEq/L</td></tr><tr><td>Mean Sr</td><td>7.472 0.0011</td><td>60.3 0.96</td><td>204.3 1.43</td><td>3.78 0.017</td><td>122 0.2</td><td>6.63 0.022</td></tr><tr><td>ST</td><td>0.0047</td><td>1.43</td><td>2.66</td><td>0.066</td><td>1.03</td><td>0.059</td></tr><tr><td>%CV</td><td>-</td><td>2.4</td><td>1.3</td><td>1.8</td><td>0.8</td><td>0.9</td></tr><tr><td>N</td><td>240</td><td>240</td><td>240</td><td>240</td><td>240</td><td>240</td></tr><tr><td>High level</td><td>Na</td><td>Glu</td><td>Lac</td><td>tHb</td><td>sO2</td><td>COHb</td></tr><tr><td>Unit</td><td>mEq/L</td><td>mg/dL</td><td>mg/dL</td><td>g/dL</td><td>%</td><td>%</td></tr><tr><td>Mean</td><td>151</td><td>264.3</td><td>144.3</td><td>21.7</td><td>99.7</td><td>38</td></tr><tr><td>Sr</td><td>0.3</td><td>2.56</td><td>3.6</td><td>0.11</td><td>0.09</td><td>0.06</td></tr><tr><td>ST</td><td>0.7</td><td>8.77</td><td>13.13</td><td>0.15</td><td>0.17</td><td>0.24</td></tr><tr><td>%CV</td><td>0.5</td><td>3.3</td><td>9.1</td><td>0.7</td><td>0.2</td><td>0.6</td></tr><tr><td>N</td><td>240</td><td>240</td><td>240</td><td>240</td><td>240</td><td>240</td></tr><tr><td>High level</td><td>MetHb</td><td>HHb</td><td>O2Hb</td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td></td><td>HbF</td><td></td><td></td></tr><tr><td>Unit</td><td>%</td><td>%</td><td>%</td><td>%</td><td></td><td></td></tr><tr><td>Mean</td><td>10.1</td><td>24.3</td><td>97.2</td><td>63.8</td><td></td><td></td></tr><tr><td>Sr</td><td>0.06</td><td>0.21</td><td>0.15</td><td>3.8</td><td></td><td></td></tr><tr><td>ST</td><td>0.23</td><td>0.32</td><td>0.23</td><td>68.4</td><td></td><td></td></tr><tr><td>%CV</td><td>2.3</td><td>1.3</td><td>0.2</td><td>10.7</td><td></td><td></td></tr><tr><td>N</td><td>240</td><td>240</td><td>240</td><td>240</td><td></td><td>*</td></tr></table>

ABL90 FLEX Precision - Capillary Study - Pooled Data from 3 Sites   

<table><tr><td>Low level</td><td>pH</td><td>pCO2 p02</td><td>Ca</td><td>Cl</td><td>K*</td></tr><tr><td>Unit</td><td>mmHg</td><td>mmHg</td><td>mEq/L</td><td>mEq/L</td><td>mEq/L</td></tr><tr><td>Mean Sr</td><td>7.271 0.0025</td><td>27.9 0.59 0.67</td><td>44.8 0.44</td><td>1.15 0.036</td><td>94 - 0.32 -</td></tr><tr><td>ST %CV</td><td>0.0044</td><td>0.91 2.4 2</td><td>0.052 4.6</td><td>1.1 1.2</td><td>-</td></tr><tr><td>N</td><td>240 240</td><td>240</td><td>240</td><td>240</td><td></td></tr><tr><td>Low level</td><td>Na Glu</td><td>Lac*</td><td>tHb</td><td>sO2</td><td>COHb</td></tr><tr><td>Unit</td><td>mEq/L mg/dL</td><td>mg/dL</td><td>g/dL</td><td>%</td><td>%</td></tr><tr><td>Mean</td><td>120 14</td><td>-</td><td>3.7</td><td>75.9</td><td></td></tr><tr><td>Sr</td><td>0.3 0.56</td><td>-</td><td>0.06</td><td>0.25</td><td>- -</td></tr><tr><td>ST</td><td>0.7 1.53</td><td>-</td><td>0.07</td><td>0.48</td><td></td></tr><tr><td>%CV</td><td>0.6 10.9</td><td></td><td>1.9</td><td>0.6</td><td>-</td></tr><tr><td>N</td><td>240 240</td><td></td><td>240</td><td>240</td><td></td></tr><tr><td>Low level</td><td>MetHb</td><td>- O2Hb</td><td></td><td></td><td></td></tr><tr><td>Unit</td><td>HHb % %</td><td>%</td><td>HbF</td><td></td><td></td></tr><tr><td>Mean</td><td>- &#x27;</td><td>74.1</td><td>%</td><td></td><td></td></tr><tr><td>Sr</td><td></td><td>0.25</td><td>I</td><td></td><td></td></tr><tr><td>ST</td><td>- -</td><td></td><td>-</td><td></td><td></td></tr><tr><td>%CV</td><td>- -</td><td>0.52</td><td>-</td><td></td><td></td></tr><tr><td></td><td></td><td>0.7</td><td></td><td></td><td></td></tr><tr><td>N</td><td></td><td>240</td><td></td><td></td><td></td></tr><tr><td>Medium level</td><td>pH</td><td>pCO2 pO2</td><td>Ca</td><td>Cl</td><td>K</td></tr><tr><td>Unit</td><td></td><td>mmHg mmHg</td><td>mEq/L</td><td>mEq/L</td><td>mEq/L</td></tr></table>

<table><tr><td>Mean</td><td>7.375</td><td>41.5</td><td>76.6</td><td>2.42</td><td>108</td><td>4.75</td></tr><tr><td>Sr</td><td>0.0022</td><td>0.63</td><td>0.78</td><td>0.017</td><td>0.36</td><td>0.039</td></tr><tr><td>ST</td><td>0.0049</td><td>0.88</td><td>1.45</td><td>0.045</td><td>1.43</td><td>0.091</td></tr><tr><td>%CV</td><td>-</td><td>2.1</td><td>1.9</td><td>1.9</td><td>1.3</td><td>1.9</td></tr><tr><td>N</td><td>240</td><td>240</td><td>240</td><td>240</td><td>240</td><td>240</td></tr><tr><td>Medium level</td><td>Na</td><td>Glu</td><td>Lac</td><td>tHb</td><td>sO2</td><td>COHb</td></tr><tr><td>Unit</td><td>mEq/L</td><td>mg/dL</td><td>mg/dL</td><td>g/dL</td><td>%</td><td>%</td></tr><tr><td>Mean</td><td>141</td><td>99</td><td>19</td><td>15</td><td>93.4</td><td>3.2</td></tr><tr><td>Sr</td><td>0.4</td><td>1.24</td><td>0.6</td><td>0.12</td><td>0.17</td><td>0.03</td></tr><tr><td>ST</td><td>0.9</td><td>3.06</td><td>1.16</td><td>0.25</td><td>0.35</td><td>0.22</td></tr><tr><td>%CV</td><td>0.7</td><td>3.1</td><td>6.1</td><td>1.6</td><td>0.4</td><td>6.7</td></tr><tr><td>N</td><td>240</td><td>240</td><td>240</td><td>240</td><td>240</td><td>240</td></tr><tr><td>Medium level</td><td>MetHb</td><td>HHb</td><td>O2Hb</td><td>HbF</td><td></td><td></td></tr><tr><td>Unit</td><td>%</td><td>%</td><td>%</td><td>%</td><td></td><td></td></tr><tr><td>Mean</td><td>3.4</td><td>6.6</td><td>89.1</td><td>41.7</td><td></td><td></td></tr><tr><td>Sr</td><td>0.09</td><td>0.22</td><td>0.23</td><td>2.38</td><td></td><td></td></tr><tr><td>ST</td><td>0.25</td><td>0.39</td><td>0.34</td><td>5.52</td><td></td><td></td></tr><tr><td>%CV</td><td>7.4</td><td>6</td><td>0.4</td><td>13.2</td><td></td><td></td></tr><tr><td>N</td><td>240</td><td>240</td><td>240</td><td>240</td><td></td><td></td></tr><tr><td>High level</td><td>pH</td><td>pCO2</td><td>pO2</td><td>Ca</td><td>Cl</td><td>K</td></tr><tr><td>Unit</td><td></td><td>mmHg</td><td>mmHg</td><td>mEq/L</td><td>mEq/L</td><td>mEq/L</td></tr><tr><td>Mean</td><td>7.473</td><td>60.5</td><td>205.2</td><td>3.79</td><td>122</td><td>6.64</td></tr><tr><td>Sr</td><td>0.0027</td><td>0.87</td><td>1.92</td><td>0.058</td><td>0.31</td><td>0.035</td></tr><tr><td>ST</td><td>0.0052</td><td>1.18</td><td>3.65</td><td>0.111</td><td>1.32</td><td>0.07</td></tr><tr><td>%CV</td><td>-</td><td>1.9</td><td>1.8</td><td>2.9</td><td>1.1</td><td>1.1</td></tr><tr><td>N</td><td>240</td><td>240</td><td>240</td><td>240</td><td>240</td><td>240</td></tr><tr><td>High level</td><td>Na</td><td>Glu</td><td>Lac</td><td>tHb</td><td>sO2</td><td>COHb</td></tr><tr><td>Unit</td><td>mEq/L</td><td>mg/dL</td><td>mg/dL</td><td>g/dL</td><td>%</td><td>%</td></tr><tr><td>Mean</td><td>151</td><td>272</td><td>143</td><td>21.6</td><td>99.8</td><td>37.3</td></tr><tr><td>Sr</td><td>0.4</td><td>3.27</td><td>3.1</td><td>0.16</td><td>0.09</td><td>0.03</td></tr><tr><td>ST</td><td>0.9</td><td>10.4</td><td>10.6</td><td>0.21</td><td>0.16</td><td>0.24</td></tr><tr><td>%CV</td><td>0.6</td><td>3.8</td><td>7.4</td><td>1</td><td>0.2</td><td>0.7</td></tr><tr><td>N</td><td>240</td><td>240</td><td>240</td><td>240</td><td>240</td><td>240</td></tr><tr><td>High level</td><td>MetHb</td><td>HHb</td><td>O2Hb</td><td>HbF</td><td></td><td></td></tr><tr><td>Unit</td><td>%</td><td>%</td><td>%</td><td>%</td><td></td><td></td></tr><tr><td>Mean</td><td>10</td><td>23.8</td><td>97.1</td><td>64</td><td></td><td></td></tr><tr><td>Sr</td><td>0.1</td><td>0.22</td><td>0.17</td><td>2.41</td><td></td><td></td></tr><tr><td>ST</td><td>0.22</td><td>0.47</td><td>0.23</td><td>5.53</td><td></td><td></td></tr><tr><td>%CV</td><td>2.2</td><td>2</td><td>0.2</td><td>8.6</td><td></td><td></td></tr><tr><td>n</td><td>240</td><td>240</td><td>240</td><td>240</td><td></td><td></td></tr></table>

\*Values were below the measuring in this study. See the in house study below that was performed for additional precision for potassium and lactate.

An in house study using blood samples covering the measuring range for potassium (13 days 10 instruments) and lactate (22 days 8 instruments) was performed. The results are presented in the table below.

<table><tr><td>cK+(meql/L)</td><td>S0</td><td>SX</td><td>CV%</td></tr><tr><td>2</td><td>0.02</td><td>0.08</td><td>4</td></tr><tr><td>4</td><td>0.01</td><td>0.08</td><td>2</td></tr><tr><td>6</td><td>0.01</td><td>0.11</td><td>1.8</td></tr><tr><td>8</td><td>0.01</td><td>0.12</td><td>1.5</td></tr><tr><td>10</td><td>0.02</td><td>0.12</td><td>1.2</td></tr></table>

<table><tr><td>cLac(mg/dL)</td><td>S0</td><td>SX</td><td>CVX%</td></tr><tr><td>4.54</td><td>0.06</td><td>0.20</td><td>4.00</td></tr><tr><td>9.08</td><td>0.09</td><td>0.70</td><td>6.99</td></tr><tr><td>13.62</td><td>0.10</td><td>0.84</td><td>5.54</td></tr><tr><td>22.70</td><td>0.22</td><td>2.11</td><td>8.44</td></tr></table>

b. Linearity/assay reportable range: Linearity Study - Study design

The linearity study was performed according to CSLI “Evaluation of the Linearity of Quantitative Measurement Procedures: A Statistical Approach; Approved Guideline. CSLI document EP6, 2003.

Each parameter was tested with one analyzer, one day, at least 7 levels (except for the parameter calcium where only 6 levels were available) and 2 replicates per level.

The study was an in-house study.

Test material was:

whole blood for pH, blood gases, pCO2, pO2, Na, K, Cl and cooximetry parameters   
standards for calcium   
serum pools for glucose and lactate.

Where whole blood was used as test material, the true values of the test material were established from measurements with a secondary instrument (predicate ABL735). Reference verified by making verification against primary reference.

Linearity Study - Results For each parameter the ABL90FLEX results were analyzed for linearity.

<table><tr><td colspan="1" rowspan="1">Parameter</td><td colspan="1" rowspan="1">Unit</td><td colspan="1" rowspan="1">Slope</td><td colspan="1" rowspan="1">Intercept</td><td colspan="1" rowspan="1">R^{2$</td><td colspan="1" rowspan="1">Reportablerange claimmed</td></tr><tr><td colspan="1" rowspan="1">pH</td><td colspan="1" rowspan="1">pH scale</td><td colspan="1" rowspan="1">0.988</td><td colspan="1" rowspan="1">0.084</td><td colspan="1" rowspan="1">0.9999</td><td colspan="1" rowspan="1">6.818 - 7.797</td></tr><tr><td colspan="1" rowspan="2">pCO2</td><td colspan="1" rowspan="1">mmHg;Torr</td><td colspan="1" rowspan="1">0.997</td><td colspan="1" rowspan="1">0.056</td><td colspan="1" rowspan="1">0.9993</td><td colspan="1" rowspan="1">15.4 - 98.3</td></tr><tr><td colspan="1" rowspan="1">kPa</td><td colspan="1" rowspan="1">0.997</td><td colspan="1" rowspan="1">0.0075</td><td colspan="1" rowspan="1">0.9993</td><td colspan="1" rowspan="1">2.05 - 13.1</td></tr><tr><td colspan="1" rowspan="2">pO2</td><td colspan="1" rowspan="1">mmHg;Torr</td><td colspan="1" rowspan="1">1.028</td><td colspan="1" rowspan="1">-1.837</td><td colspan="1" rowspan="1">1.0000</td><td colspan="1" rowspan="1">30.1 - 488</td></tr><tr><td colspan="1" rowspan="1">kPa</td><td colspan="1" rowspan="1">1.028</td><td colspan="1" rowspan="1">-0.24</td><td colspan="1" rowspan="1">1.000</td><td colspan="1" rowspan="1">4.0 - 65.0</td></tr><tr><td colspan="1" rowspan="3">ctHb</td><td colspan="1" rowspan="1">g/dL</td><td colspan="1" rowspan="1">0.999</td><td colspan="1" rowspan="1">0.0978</td><td colspan="1" rowspan="1">0.9999</td><td colspan="1" rowspan="1">0.1 - 24.0</td></tr><tr><td colspan="1" rowspan="1">g/L</td><td colspan="1" rowspan="1">0.999</td><td colspan="1" rowspan="1">0.978</td><td colspan="1" rowspan="1">0.9999</td><td colspan="1" rowspan="1">0.8 - 240</td></tr><tr><td colspan="1" rowspan="1">mmol/L</td><td colspan="1" rowspan="1">0.999</td><td colspan="1" rowspan="1">0.061</td><td colspan="1" rowspan="1">0.9999</td><td colspan="1" rowspan="1">0.05 - 14.9</td></tr><tr><td colspan="1" rowspan="2">sO2</td><td colspan="1" rowspan="1">%</td><td colspan="1" rowspan="1">0.998</td><td colspan="1" rowspan="1">-0.153</td><td colspan="1" rowspan="1">1.0000</td><td colspan="1" rowspan="1">3.3 - 100.0</td></tr><tr><td colspan="1" rowspan="1">fraction</td><td colspan="1" rowspan="1">0.998</td><td colspan="1" rowspan="1">0.0006</td><td colspan="1" rowspan="1">1.0000</td><td colspan="1" rowspan="1">0.033 - 1.000</td></tr><tr><td colspan="1" rowspan="2">FO2Hb</td><td colspan="1" rowspan="1">%</td><td colspan="1" rowspan="1">0.996</td><td colspan="1" rowspan="1">-0.054</td><td colspan="1" rowspan="1">0.9999</td><td colspan="1" rowspan="1">3.3-98.5</td></tr><tr><td colspan="1" rowspan="1">fraction</td><td colspan="1" rowspan="1">0.996</td><td colspan="1" rowspan="1">-0.001</td><td colspan="1" rowspan="1">0.9999</td><td colspan="1" rowspan="1">0.033- 0.985</td></tr><tr><td colspan="1" rowspan="2">FCOHb</td><td colspan="1" rowspan="1">%</td><td colspan="1" rowspan="1">1.004</td><td colspan="1" rowspan="1">0.1083</td><td colspan="1" rowspan="1">1.0000</td><td colspan="1" rowspan="1">1.0 - 92.2</td></tr><tr><td colspan="1" rowspan="1">fraction</td><td colspan="1" rowspan="1">1.004</td><td colspan="1" rowspan="1">0.0011</td><td colspan="1" rowspan="1">1.0000</td><td colspan="1" rowspan="1">0.010 - 0.922</td></tr><tr><td colspan="1" rowspan="2">FMetHb</td><td colspan="1" rowspan="1">%</td><td colspan="1" rowspan="1">1.002</td><td colspan="1" rowspan="1">0.0168</td><td colspan="1" rowspan="1">1.0000</td><td colspan="1" rowspan="1">1.0 - 91.0</td></tr><tr><td colspan="1" rowspan="1">fraction</td><td colspan="1" rowspan="1">1.002</td><td colspan="1" rowspan="1">0.0002</td><td colspan="1" rowspan="1">1.0000</td><td colspan="1" rowspan="1">0.010 - 0.910</td></tr><tr><td colspan="1" rowspan="2">FHHb</td><td colspan="1" rowspan="1">%</td><td colspan="1" rowspan="1">1.000</td><td colspan="1" rowspan="1">0.290</td><td colspan="1" rowspan="1">1.0000</td><td colspan="1" rowspan="1">2.4 -98.5</td></tr><tr><td colspan="1" rowspan="1">fraction</td><td colspan="1" rowspan="1">1.000</td><td colspan="1" rowspan="1">0.0029</td><td colspan="1" rowspan="1">1.0000</td><td colspan="1" rowspan="1">0.024 - 0.985</td></tr><tr><td colspan="1" rowspan="2">FHbF</td><td colspan="1" rowspan="1">%</td><td colspan="1" rowspan="1">0.925</td><td colspan="1" rowspan="1">3.96</td><td colspan="1" rowspan="1">0.9977</td><td colspan="1" rowspan="1">21-83</td></tr><tr><td colspan="1" rowspan="1">fraction</td><td colspan="1" rowspan="1">0.925</td><td colspan="1" rowspan="1">0.040</td><td colspan="1" rowspan="1">0.997</td><td colspan="1" rowspan="1">0.21 - 0.83</td></tr><tr><td colspan="1" rowspan="1">cK*</td><td colspan="1" rowspan="1">mmol/L;meq/L</td><td colspan="1" rowspan="1">0.984</td><td colspan="1" rowspan="1">0.164</td><td colspan="1" rowspan="1">0.9998</td><td colspan="1" rowspan="1">2.1 - 10.5</td></tr><tr><td colspan="1" rowspan="1">cNa+</td><td colspan="1" rowspan="1">mmol/L;meq/L</td><td colspan="1" rowspan="1">1.017</td><td colspan="1" rowspan="1">-1.730</td><td colspan="1" rowspan="1">0.9998</td><td colspan="1" rowspan="1">116 - 180</td></tr><tr><td colspan="1" rowspan="3">cCa2+</td><td colspan="1" rowspan="1">mmol/L</td><td colspan="1" rowspan="1">0.992</td><td colspan="1" rowspan="1">0.026</td><td colspan="1" rowspan="1">0.9999</td><td colspan="1" rowspan="1">0.50 - 2.48</td></tr><tr><td colspan="1" rowspan="1">meq/L</td><td colspan="1" rowspan="1">0.992</td><td colspan="1" rowspan="1">0.052</td><td colspan="1" rowspan="1">0.9999</td><td colspan="1" rowspan="1">1.00 - 4.96</td></tr><tr><td colspan="1" rowspan="1">mg/dL</td><td colspan="1" rowspan="1">0.992</td><td colspan="1" rowspan="1">0.104</td><td colspan="1" rowspan="1">0.9999</td><td colspan="1" rowspan="1">2.00 - 9.92</td></tr><tr><td colspan="1" rowspan="1">cCl</td><td colspan="1" rowspan="1">mmol/L;meq/L</td><td colspan="1" rowspan="1">0.993</td><td colspan="1" rowspan="1">1.825</td><td colspan="1" rowspan="1">0.9997</td><td colspan="1" rowspan="1">86 - 151</td></tr><tr><td colspan="1" rowspan="1">cGlu</td><td colspan="1" rowspan="1">mmol/L</td><td colspan="1" rowspan="1">0.977</td><td colspan="1" rowspan="1">0.185</td><td colspan="1" rowspan="1">0.9998</td><td colspan="1" rowspan="1">0.5 - 41</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">mg/dL</td><td colspan="1" rowspan="1">0.977</td><td colspan="1" rowspan="1">3.33</td><td colspan="1" rowspan="1">0.9998</td><td colspan="1" rowspan="1">9 - 738</td></tr><tr><td colspan="1" rowspan="2">cLac</td><td colspan="1" rowspan="1">mmol/L;meq/L</td><td colspan="1" rowspan="1">1.050</td><td colspan="1" rowspan="1">-0.060</td><td colspan="1" rowspan="1">0.9997</td><td colspan="1" rowspan="1">0.4 - 24</td></tr><tr><td colspan="1" rowspan="1">mg/dL</td><td colspan="1" rowspan="1">1.050</td><td colspan="1" rowspan="1">-0.541</td><td colspan="1" rowspan="1">0.9997</td><td colspan="1" rowspan="1">4 - 216</td></tr></table>

c. Traceability, Stability, Expected values (controls, calibrators, or methods):

Calibrators and controls are for all parameters except $\mathsf { p H }$ and ctHb traceable to NIST certified reference materials. pH is traceable to standards certified by the Danish Primary Laboratory for Electrochemistry and ctHb is traceable to a Haemoglobin Cyanide standard from J.T. Baker.

The final stability claim will be based on real-time data for both the Solution Pack and the Sensor Cassette. Real-time testing will be ongoing, until the full test plans covered in the stability protocols are completed. The following stability that will be claimed at the time of release of the ABL 90 for the US market:

6-month lifetime for the Solution Pack based on 12 months real-time test on three lots.   
4-month lifetime for the Sensor Cassette based on 6 months real-time test on three lots.

# d. Detection limit:

LoB, LoD and LoQ were established following the guideline CSLI. Protocols for Determination of Limits of Detection and Limits of Quantitation; Approved Guideline,CSLI document EP17-A   

<table><tr><td rowspan=1 colspan=1>Parameter</td><td rowspan=1 colspan=1>LoB</td><td rowspan=1 colspan=1>LoD</td><td rowspan=1 colspan=1>LoQ</td></tr><tr><td rowspan=1 colspan=1>Ca</td><td rowspan=1 colspan=1>0.143 mM0.572 mg/dL</td><td rowspan=1 colspan=1>0.151 mM0.606 mg/dL</td><td rowspan=1 colspan=1>0.417 mM1.666 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Glu</td><td rowspan=1 colspan=1>0.33 mM5.98 mg/dL</td><td rowspan=1 colspan=1>0.47 mM8.52 mg/dL</td><td rowspan=1 colspan=1>0.47 mM8.52 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Lac</td><td rowspan=1 colspan=1>-0.008 mM-0.07 mg/dL</td><td rowspan=1 colspan=1>0.05 mM0.45 mg/dL</td><td rowspan=1 colspan=1>0.27 mM2.41 mg/dL</td></tr><tr><td rowspan=1 colspan=1>tHb</td><td rowspan=1 colspan=1>0.042 g/dL</td><td rowspan=1 colspan=1>0.062 g/dL</td><td rowspan=1 colspan=1>0.084 g/dL</td></tr><tr><td rowspan=1 colspan=1>sO2</td><td rowspan=1 colspan=1>0.316%</td><td rowspan=1 colspan=1>1.038%</td><td rowspan=1 colspan=1>3.306%</td></tr><tr><td rowspan=1 colspan=1>O2Hb</td><td rowspan=1 colspan=1>0.316%</td><td rowspan=1 colspan=1>1.038%</td><td rowspan=1 colspan=1>3.306%</td></tr><tr><td rowspan=1 colspan=1>HHb</td><td rowspan=1 colspan=1>0.124%</td><td rowspan=1 colspan=1>0.615%</td><td rowspan=1 colspan=1>2.42%</td></tr><tr><td rowspan=1 colspan=1>COHb</td><td rowspan=1 colspan=1>Not determined</td><td rowspan=1 colspan=1>Not determined</td><td rowspan=1 colspan=1>1%</td></tr><tr><td rowspan=1 colspan=1>MetHb</td><td rowspan=1 colspan=1>Not determined</td><td rowspan=1 colspan=1>Not determined</td><td rowspan=1 colspan=1>1%</td></tr><tr><td rowspan=1 colspan=1>HbF</td><td rowspan=1 colspan=1>5.8%</td><td rowspan=1 colspan=1>11.4%</td><td rowspan=1 colspan=1>21%</td></tr></table>

e. Analytical specificity:

# a. Study design

R adiometer has defined interference limits parameters that are analyte specific to determine whether a suspected interferent is considered an interferent or not. The difference between test results for a sample with and without suspected interferent was compared to the target and the parameters were tested at their normal physiological levels. Radiome ter tested levels of interferents that are close to the required levels provided by the standard EP7-A2.

# Results

# pH/BG

een tested for interference from Intralipid, Fluorescein,pH has b $\mathrm { K } ^ { + }$ , $\mathrm { N a } ^ { + }$ , $\mathrm { \bar { C } } \mathbf { a } ^ { + + }$ , hemolysis, unconj. Bilirubin and conj. Bilirubin. No interference was seen at the levels tested.

$\pmb { p } \mathbf { 0 } _ { 2 }$ has been tested for interference from Intralipid, Fluorescein, nterferehemolysis, unconj. Bilirubin and conj. Bilirubin. Hemolysis will i with the $p \mathrm { O } _ { 2 }$ test when present in an amount greater than $1 3 . 3 \%$ ( $20 \%$ hemolysis corresponds to $2 . 8 \mathrm { m g / d L }$ hemoglobin). No interference was seen from the other tested compounds at the levels tested.

$\pmb { p } \mathbf { C } \mathbf { O } _ { 2 }$ has been tested for interference from hemolysis, unconj. Bilirubin and conj. Bilirubin. No interference was seen at the levels tested.

# Electrolytes

$\mathrm { K } +$ was tested for interference from $\operatorname { L i } +$ , $\mathrm { C a + + }$ , $\mathrm { N H } 4 + , \mathrm { Z n ^ { + } }$ in and conj.,benzalkonium chloride, hemolysis, Intralipid, unconj. Bilirub Bilirubin. Benzalkonium chloride will interfere with the $\mathrm { K } +$ test if present in an amount greater than $2 . 4 ~ \mathrm { m g / m L }$ . Hemolysis will interfere with the $\mathrm { K } +$ test if present in an amount greater than $0 . 1 5 \%$ . No interference was seen from the other tested compounds at the levels tested.

$\mathrm { N a + }$ was tested for interference from $\operatorname { L i } +$ , $\mathrm { K } +$ , $\mathrm { C a + + }$ , $\mathrm { N H 4 + , M g ^ { + + } }$ , $Z \mathrm { n + }$ , benzalkonium chloride, hemolysis, Intralipid, unconj. Bilirubin and conj. Bilirubin. $\mathrm { C a + + }$ will interfere with the $\mathrm { N a + }$ test if present in an amount greater than $2 . 7 \ \mathrm { m M } / 5 . 4 \ \mathrm { m E q / L }$ . Benzalkonium chloride will interfere with the $\mathrm { N a + }$ test if present in an amount greater than $0 . 7 5 ~ \mathrm { m g / m L }$ . Hemolysis will interfere with the $\mathrm { N a + }$ eater test if present in an amount gr than $0 . 8 5 \%$ . Intralipid will interfere with the $\mathrm { N a + }$ test if present in an amount greater than $2 \%$ . Conj. Bilirubin will interfere with the $\mathrm { N a + }$ st if  te present in an amount greater than $1 7 . 9 \mathrm { m g / d L }$ No interference was seen from the other tested compounds at the levels tested.

$\mathrm { C a + + }$ was tested for interference from $\operatorname { L i } +$ , $\mathrm { K } +$ , $\mathrm { N a + }$ , $\mathrm { M g ^ { + + } }$ , $Z \mathrm { n + }$ , $\mathrm { S r ^ { + } }$ , $\mathsf { p H }$ , perchlorate, benzalkonium chloride, hemolysis, Intralipid, unconj. Bilirubin and conj. Bilirubin. $\mathrm { N a + }$ will interfere with the $\mathrm { C a + + }$ test if present in an amount greater than $1 6 8 \mathrm { m M } \mathrm { m E q } / \mathrm { L }$ . $\mathrm { M g ^ { + + } }$ will interfere with the $\mathrm { C a + + }$ test if present in an amount greater than $1 4 . 1 \mathrm { m M }$ $2 8 . 2 \mathrm { m E q / L }$ . $Z \mathrm { n + }$ will interfere with the $\mathrm { C a + + }$ test if present in an amount greater than $1 4 0 \mathrm { m M }$ . pH will interfere with the $\mathrm { C a + + }$ test if sample $\mathsf { p H }$ is changed more than $0 . 5 4 \mathrm { p H }$ units. Benzalkonium chloride will interfere with the $\mathrm { C a + + }$ test if present in an amount greater than $1 \mathrm { m g / m L }$ . Hemolysis will interfere with the $\mathrm { C a + + }$ test if present in an amount greater than $0 . 4 7 \%$ . No interference was seen from the other tested compounds at the levels tested.

Cl- was tested for interference from $\mathrm { N H 4 + , p H }$ , Br-, I-, F-, ClO4 -, benzalkonium chloride, acetylsalicylic acid, salicylic acid, thiocyanic acid, ascorbic acid, citrate, oxalate, lactate, caprylic acid, acetyltryptophane, hemolysis, Intralipid, unconj. Bilirubin and conj. Bilirubin. $\mathrm { N H } 4 + \mathrm { w i l l }$ interfere with the Cl- test if present in an amount greater than $0 . 9 \mathrm { m M }$ $1 . 5 \mathrm { m g / d L }$ . Br- will interfere with the Cl- test if present in an amount greater than $0 . 5 \mathrm { m M / m E q / L }$ . I- will interfere with the Cl- test if present in an amount greater than $0 . 3 \mathrm { m M } \mathrm { m E q } / \mathrm { L }$ . Perchlorate will interfere with the Cl- test if present in an amount greater than $0 . 2 \mathrm { m M } \mathrm { m E q } / \mathrm { L }$ .

Acetylsalicylic acid will interfere with the Cl- test if present in an amount greater than $1 . 7 \ : \mathrm { m M } / \ : 0 . 3 1 \mathrm { g / L }$ . Salicylic acid will interfere with the Cl- test if present in an amount greater than $1 . 5 \ : \mathrm { m M } / \ : 0 . 2 \mathrm { g / L }$ . Thiocyanic acid will interfere with the Cl- test if present in an amount greater than $0 . 1 ~ \mathrm { m M }$ $6 \mu \mathrm { g / L }$ . Citrate will interfere with the Cl- test if present in an amount greater than $8 \mathrm { m M } / 1 . 5 \mathrm { g / L }$ . Hemolysis will interfere with the Cl- test if present in an amount greater than $1 . 2 7 \%$ . Intralipid will interfere with the Cl- test if present in an amount greater than $3 \%$ . Unconj. Bilirubin will interfere with the Cl- test if present in an amount greater than $2 9 . 2 \ : \mathrm { m g / d L }$ . No interference was seen from the other tested compounds at the levels tested.

# Metabolites

Glu was tested for interference from Acetominophen (Paracetamol), acetylsalicylic acid, Ibuprofen (sodium), dopamine HCl, chlorpromazine HCl, ethanol, glucosamine HCl, glycolic acid, lactic acid, maltose (monohydrate), mannose, salicylic acid, sodium thiocyanate, xylose, acetoacetate (lithium acetacetoacetate), creatinine, galactose, pyruvate (pyruvic acid sodium salt), urea, uric acid, heparin, EDTA (edetate disodium $2 \mathrm { H } _ { 2 } \mathrm { O } _ { \cdot }$ ), citrate (sodium citrate 2H2O), oxalate (sodium oxalate), fluoride (sodium fluoride), pralidoxime chloride, 2-deoxy glucose, unconjugated bilirubin, conjugated bilirubin, ascorbic acid, Intralipid and hemolysis. Glucosamine HCl will interfere with the Glu test if present in an amount greater than $1 . 6 7 \mathrm { m M }$ . Mannose will interfere with the Glu test if present in an amount greater than $0 . 9 \mathrm { m M }$ . Sodium thiocyanate will interfere with the Glu test if present in an amount greater than $0 . 0 6 5 \mathrm { m M }$ . Galactose will interfere with the Glu test if present in an amount greater than $2 . 3 ~ \mathrm { m M }$ . Hemolysis will interfere with the Glu test if present in an amount greater than $8 . 3 \%$ . No interference was seen from the other tested compounds at the levels tested

Lac was tested for interference from Acetominophen (Paracetamol), acetylsalicylic acid, Ibuprofen (sodium), dopamine HCl, chlorpromazine HCl, ethanol, glucosamine HCl, glycolic acid, maltose (monohydrate), mannose, salicylic acid, sodium thiocyanate, xylose, acetoacetate (lithium acetacetoacetate), creatinine, galactose, D-glucose, pyruvate (pyruvic acid sodium salt), urea, uric acid, heparin, EDTA (edetate disodium $2 \mathrm { H } _ { 2 } \mathrm { O }$ ), citrate (sodium citrate $2 \mathrm { H } _ { 2 } \mathrm { O } _ { \cdot }$ ), oxalate (sodium oxalate), fluoride (sodium fluoride), pralidoxime chloride, unconjugated bilirubin, conjugated bilirubin, ascorbic acid, Intralipid and hemolysis. Glycolic acid will interfere with the Lac test if present in an amount greater than $0 . 0 8 \mathrm { m M }$ . Sodium thiocyanate will interfere with the Lac test if present in an amount greater than $0 . 0 7 \mathrm { m M }$ . Acetoacetate (Lithium acetacetoacetate) will interfere with the Lac test if present in an amount greater than $1 . 8 \mathrm { m M }$ . DGlucose will interfere with the Lac test if present in an amount greater than $3 2 \mathrm { m M }$ . Fluoride (sodium fluoride) will interfere with the Lac test if present in an amount greater than $3 8 ~ \mathrm { m M }$ . No interference was seen from the other tested compounds at the levels tested.

# Co-oximetry

The co-oximetry parameters were all tested for interference from pH, Fluorescein, beta-carotene, Patent Blue V, Methylene Blue, Cardio Green, Evans Blue, Intralipid, HiCN, SHb, hydroxycobalamin, cyanocobalamin and hemolysis. In addition all parameters except bilirubin were tested for interference from bilirubin (unconj.)and bilirubin (conj.). ctHb Fluorescein will interfere with the ctHb test if present in an amount greater than 95 $\mathrm { m g / L }$ . Methylene Blue will interfere with the ctHb test if present in an amount greater than $1 0 \mathrm { m g / L }$ . HiCN will interfere with the ctHb test if present in an amount greater than $1 3 \%$ . SHb will interfere with ctHb test if present in an amount greater than $5 \%$ . Hydroxy-cobalamin will interfere with the ctHb test if present in an amount greater than $0 . 4 \mathrm { g / L }$ . Cyanocobalamin will interfere with ctHb test if present in an amount greater than $0 . 4 \ : \mathrm { g / L }$ . No interference was seen from the other tested compounds at the levels tested.

${ \tt s O 2 - p H }$ will interfere with the sO2 test if sample $\mathsf { p H }$ is changed more than $0 . 5 \mathrm { p H }$ units. Fluorescein will interfere with the sO2 test if present in an amount greater than $7 8 \mathrm { m g / L }$ . Methylene Blue will interfere with the $\mathbf { s } \mathbf { O } 2$ test if present in an amount greater than $1 4 ~ \mathrm { m g / L }$ . SHb will interfere with the sO2 test if present in an amount greater than $2 9 \%$ .

Cyanocobalamin will interfere with the sO2 test if present in an amount greater than $0 . 5 \mathrm { g / L }$ . No interference was seen from the other tested compounds at the levels tested.

FO2Hb - pH will interfere with the FO2Hb test if sample $\mathsf { p H }$ is changed more than $0 . 2 \mathrm { p H }$ units. Fluorescein will interfere with the FO2Hb test if present in an amount greater than $2 6 \mathrm { m g / L }$ . Patent Blue $\mathrm { V }$ will interfere with the FO2Hb test if present in an amount greater than $7 \mathrm { m g / L }$ . Methylene Blue will interfere with the FO2Hb test if present in an amount greater than $2 \mathrm { m g / L }$ . Cardio Green will interfere with the FO2Hb test if present in an amount greater than $1 8 \mathrm { m g / L }$ . Intralipid will interfere with the FO2Hb test if present in an amount greater than $3 . 5 \%$ . SHb will interfere with the FO2Hb test if present in an amount greater than $8 \%$ . Hydroxycobalamin will interfere with the FO2Hb test if present in an amount greater than $0 . 1 \mathrm { g / L }$ . Cyanocobalamin will interfere with FO2Hb test if present in an amount greater than $0 . 1 \mathrm { g / L }$ . No interference was seen from the other tested compounds at the levels tested.

FCOHb - Fluorescein will interfere with the FCOHb test if present in an amount greater than $6 1 ~ \mathrm { m g / L }$ . Methylene Blue will interfere with the FCOHb test if present in an amount greater than $5 0 \mathrm { m g / L }$ . Hydroxycobalamin will interfere with the FCOHb test if present in an amount greater than $0 . 8 \mathrm { g / L }$ . Cyanocobalamin will interfere with FCOHb test if present in an amount greater than $0 . 7 \mathrm { g / L }$ . No interference was seen from the other tested compounds at the levels tested.

FMetHb - pH will interfere with the FMetHb test if sample $\mathsf { p H }$ is changed more than $0 . 4 \mathrm { p H }$ units. Fluorescein will interfere with the FMetHb test if present in an amount greater than $2 3 \mathrm { m g / L }$ . Methylene Blue will interfere with the FMetHb test if present in an amount greater than $2 . 5 \mathrm { m g / L }$ . Cardio Green will interfere with the FMetHb test if present in an amount greater than $2 5 \mathrm { m g / L }$ . SHb will interfere with the FMetHb test if present in an amount greater than $7 \%$ . Hydroxycobalamin will interfere with the FMetHb test if present in an amount greater than $0 . 1 \mathrm { g / L }$ . Cyanocobalamin will interfere with FMetHb test if present in an amount greater than $0 . 2 \mathrm { g / L }$ . No interference was seen from the other tested compounds at the levels tested.

FHHb - pH will interfere with the FHHb test if sample $\mathsf { p H }$ is changed more than $0 . 5 \mathrm { p H }$ units. Fluorescein will interfere with the FHHb test if present in an amount greater than $8 6 ~ \mathrm { m g / L }$ . Methylene Blue will interfere with the FHHb test if present in an amount greater than $1 1 \mathrm { m g / L }$ . SHb will interfere with the FHHb test if present in an amount greater than $31 \%$ . Cyanocobalamin will interfere with the FHHb test if present in an amount greater than $0 . 6 \mathrm { g / L }$ . No interference was seen from the other tested compounds at the levels tested.

FHbF - pH will interfere with the FHbF test if sample $\mathsf { p H }$ is changed more than $0 . 6 \mathrm { p H }$ units. Fluorescein, Patent Blue V, Methylene Blue, Cardio Green, HiCN, SHb, hydroxycobalamin and cyanocobalamin will all interfere to such an extent that the ABL90FLEX software will determine that the spectra are abnormal. Hence no values are displayed by the ABL90FLEX. No interference was seen from the other tested compounds at the levels tested.

f. Assay cut-off: Not Applicable

2. Comparison studies:

a. Method comparison with predicate device:

Method comparison studies were performed at four user sites. The purpose was to evaluate whether the ABL90 FLEX is equivalent to a current test method for each of the parameters measured by the ABL90FLEX analyzer (pH, pCO2, pO2, Ca, Cl, K, Na, Glu, Lac, tHb, sO2, FO2Hb, FHHb, FCOHb, FMetHb, FHbF). The studies were conducted in a point-of-care setting and were using methods described in CLSI. “Method Comparison and Bias Estimation Using Patient Samples; Approved Guideline – Second Edition”, CLSI EP9-A2.

The material used was random patient samples and spiked blood samples.   
Spiked samples were needed in order to support the full reportable range.

In each study sample handling and sample transfer were performed by multiple POC staff members.

The studies were performed in both syringe mode and capillary mode of the ABL90FLEX.

Pooled data for Site 1, 2 and 3: ABL90FLEX in Syringe mode vs. Predicate device

<table><tr><td colspan="1" rowspan="1">Parameter</td><td colspan="1" rowspan="1">Units</td><td colspan="1" rowspan="1">RangeLow</td><td colspan="1" rowspan="1">RangeHigh</td><td colspan="1" rowspan="1">Totaln</td><td colspan="1" rowspan="1">Slope</td><td colspan="1" rowspan="1">Intercept</td><td colspan="1" rowspan="1">R^{2}$</td><td colspan="1" rowspan="1">Syx</td></tr><tr><td colspan="1" rowspan="1">pH</td><td colspan="1" rowspan="1">N/A</td><td colspan="1" rowspan="1">6.840</td><td colspan="1" rowspan="1">7.774</td><td colspan="1" rowspan="1">652</td><td colspan="1" rowspan="1">1.02</td><td colspan="1" rowspan="1">-0.18</td><td colspan="1" rowspan="1">0.9915</td><td colspan="1" rowspan="1">0.011</td></tr><tr><td colspan="1" rowspan="1">CO2</td><td colspan="1" rowspan="1">kPammHg</td><td colspan="1" rowspan="1">2.115.5</td><td colspan="1" rowspan="1">13.198.3</td><td colspan="1" rowspan="1">636636</td><td colspan="1" rowspan="1">0.990.99</td><td colspan="1" rowspan="1">0.040.27</td><td colspan="1" rowspan="1">0.99270.9927</td><td colspan="1" rowspan="1">0.151.09</td></tr><tr><td>Parameter</td><td>Units</td><td>Range Low</td><td>Range High</td><td>Total n</td><td>Slope</td><td>Intercept</td><td>$R^{2}$</td><td>Sy.x</td></tr><tr><td rowspan="2">pO2</td><td rowspan="2">kPa mmHg</td><td>4.0</td><td>65.0</td><td>588</td><td>1.04</td><td>-0.39</td><td>0.9979</td><td>0.43</td></tr><tr><td>30.1</td><td>487.5</td><td>588</td><td>1.04</td><td>-2.94</td><td>0.9979</td><td>3.25</td></tr><tr><td rowspan="2">cCa2+</td><td rowspan="2">mEq/L mM</td><td>1.00</td><td>4.96</td><td>649</td><td>1.10</td><td>-0.15</td><td>0.9937</td><td>0.04</td></tr><tr><td>0.50</td><td>2.48</td><td>649</td><td>1.10</td><td>-0.07</td><td>0.9937</td><td>0.02</td></tr><tr><td rowspan="2">cCl</td><td rowspan="2">mEq/L mM</td><td>86</td><td>149</td><td>618</td><td>0.99</td><td>0.71</td><td>0.9816</td><td>1.11</td></tr><tr><td>86</td><td>149</td><td>618</td><td>0.99</td><td>0.71</td><td>0.9816</td><td>1.11</td></tr><tr><td rowspan="2">cK+</td><td rowspan="2">mEq/L mM</td><td>2.2</td><td>10.5</td><td>654</td><td>1.00</td><td>0.17</td><td>0.9949</td><td>0.08</td></tr><tr><td>2.2</td><td>10.5</td><td>654</td><td>1.00</td><td>0.17</td><td>0.9949</td><td>0.08</td></tr><tr><td rowspan="2">cNa+</td><td rowspan="2">mEq/L mM</td><td>116</td><td>180</td><td>657</td><td>1.05</td><td>-5.91</td><td>0.9906</td><td>0.85</td></tr><tr><td>116</td><td>180</td><td>657</td><td>1.05</td><td>-5.91</td><td>0.9906</td><td>0.85</td></tr><tr><td rowspan="2">cGlu</td><td rowspan="2">mg/dL mM</td><td>11</td><td>702</td><td>655</td><td>0.96</td><td>-1.16</td><td>0.9943</td><td>6.48</td></tr><tr><td>0.6</td><td>39.0</td><td>655</td><td>0.96</td><td>-0.06</td><td>0.9943</td><td>0.36</td></tr><tr><td rowspan="2">cLac</td><td rowspan="2">mg/dL mM</td><td>4</td><td>216</td><td>670</td><td>0.87</td><td>1.56</td><td>0.9748</td><td>4.66</td></tr><tr><td>0.4</td><td>24.0</td><td>670</td><td>0.87</td><td>0.17</td><td>0.9748</td><td>0.52</td></tr><tr><td>ctHb</td><td>g/dL</td><td>1.0</td><td>23.8</td><td>654</td><td>0.95</td><td>0.34</td><td>0.9914</td><td>0.31</td></tr><tr><td></td><td>%</td><td>6.1</td><td>100.0</td><td>626</td><td>1.00</td><td>-0.45</td><td>0.9981</td><td>0.75</td></tr><tr><td>FHHb</td><td>%</td><td>2.4</td><td>98.5</td><td>468</td><td>1.00</td><td>0.23</td><td>0.9980</td><td>0.84</td></tr><tr><td>FOHb</td><td>%</td><td>5.5</td><td>98.5</td><td>629</td><td>1.00</td><td>-0.23</td><td>0.9983</td><td>0.75</td></tr><tr><td>FCOHb</td><td>%</td><td>1.0</td><td>89.3</td><td>596</td><td>1.00</td><td>0.20</td><td>0.9989</td><td>0.31</td></tr><tr><td>FMetHb</td><td>%</td><td>1.0</td><td>83.3</td><td>202</td><td>1.00</td><td>-0.01</td><td>0.9993</td><td>0.35</td></tr><tr><td>FHbF</td><td>%</td><td>21</td><td>78</td><td>30</td><td>1.10</td><td>-5.28</td><td>0.8747</td><td>6.70</td></tr></table>

Pooled data for Site 1, 4 and 3: ABL90FLEX in Capillary mode vs. Predicate device   

<table><tr><td>Parameter</td><td>Units</td><td>Range Low</td><td>Range High</td><td>Total n</td><td>Slope</td><td>Intercept</td><td>$R^{}$</td><td>Sy.x</td></tr><tr><td>pH</td><td>N/A</td><td>6.824</td><td>7.797</td><td>465</td><td>0.99</td><td>0.09</td><td>0.9898</td><td>0.012</td></tr><tr><td rowspan="2">pCO2</td><td rowspan="2">kPa mmHg</td><td>2.1</td><td>12.9</td><td>465</td><td>0.95</td><td>0.14</td><td>0.9895</td><td>0.20</td></tr><tr><td>15.5</td><td>96.8</td><td>465</td><td>0.95</td><td>1.04</td><td>0.9895</td><td>1.51</td></tr><tr><td rowspan="2">pO2</td><td rowspan="2">kPa mmHg</td><td>4.1</td><td>62.2</td><td>441</td><td>0.99</td><td>0.17</td><td>0.9969</td><td>0.50</td></tr><tr><td>30.5</td><td>466.5</td><td>441</td><td>0.99</td><td>1.26</td><td>0.9969</td><td>3.75</td></tr><tr><td rowspan="2">cCa2+</td><td rowspan="2">mEq/L mM</td><td>1.02</td><td>4.74</td><td>438</td><td>0.96</td><td>0.09</td><td>0.9795</td><td>0.05</td></tr><tr><td>0.51</td><td>2.37</td><td>438</td><td>0.96</td><td>0.04</td><td>0.9795</td><td>0.03</td></tr><tr><td rowspan="2">cCr</td><td rowspan="2">mEq/L mM</td><td>86</td><td>150</td><td>446</td><td>1.00</td><td>-0.12</td><td>0.9663</td><td>1.71</td></tr><tr><td>86</td><td>150</td><td>446</td><td>1.00</td><td>-0.12</td><td>0.9663</td><td>1.71</td></tr><tr><td rowspan="2">cK+</td><td rowspan="2">mEq/L mM</td><td>2.1</td><td>10.5</td><td>458</td><td>1.01</td><td>-0.06</td><td>0.9952</td><td>0.09</td></tr><tr><td>2.1</td><td>10.5</td><td>458</td><td>1.01</td><td>-0.06</td><td>0.9952</td><td>0.09</td></tr><tr><td rowspan="2">cNa+</td><td rowspan="2">mEq/L mM</td><td>117</td><td>176</td><td>462</td><td>1.07</td><td>-8.49</td><td>0.9870</td><td>0.93</td></tr><tr><td>117</td><td>176</td><td>462</td><td>1.07</td><td>-8.49</td><td>0.9870</td><td>0.93</td></tr><tr><td rowspan="2">cGlu</td><td rowspan="2">mg/dL mM</td><td>9</td><td>738</td><td>466</td><td>1.00</td><td>-1.43</td><td>0.9962</td><td>6.02</td></tr><tr><td>0.5</td><td>41.0</td><td>466</td><td>1.00</td><td>-0.08</td><td>0.9962</td><td>0.33</td></tr><tr><td colspan="1" rowspan="1">Parameter</td><td colspan="1" rowspan="1">Units</td><td colspan="1" rowspan="1">RangeLow</td><td colspan="1" rowspan="1">RangeHigh</td><td colspan="1" rowspan="1">Totaln</td><td colspan="1" rowspan="1">Slope</td><td colspan="1" rowspan="1">Intercept</td><td colspan="1" rowspan="1">$R^{2}$</td><td colspan="1" rowspan="1">Sy.x</td></tr><tr><td colspan="1" rowspan="1">cLac</td><td colspan="1" rowspan="1">mg/dLmM</td><td colspan="1" rowspan="1">40.4</td><td colspan="1" rowspan="1">19822.0</td><td colspan="1" rowspan="1">447447</td><td colspan="1" rowspan="1">1.051.05</td><td colspan="1" rowspan="1">-1.71-0.19</td><td colspan="1" rowspan="1">0.98050.9805</td><td colspan="1" rowspan="1">4.280.48</td></tr><tr><td colspan="1" rowspan="1">ctHb</td><td colspan="1" rowspan="1">g/dL</td><td colspan="1" rowspan="1">0.6</td><td colspan="1" rowspan="1">24.0</td><td colspan="1" rowspan="1">468</td><td colspan="1" rowspan="1">0.99</td><td colspan="1" rowspan="1">0.20</td><td colspan="1" rowspan="1">0.9947</td><td colspan="1" rowspan="1">0.27</td></tr><tr><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">%</td><td colspan="1" rowspan="1">11.8</td><td colspan="1" rowspan="1">100.0</td><td colspan="1" rowspan="1">450</td><td colspan="1" rowspan="1">1.00</td><td colspan="1" rowspan="1">-0.55</td><td colspan="1" rowspan="1">0.9973</td><td colspan="1" rowspan="1">0.78</td></tr><tr><td colspan="1" rowspan="1">FHHb</td><td colspan="1" rowspan="1">%</td><td colspan="1" rowspan="1">2.4</td><td colspan="1" rowspan="1">98.5</td><td colspan="1" rowspan="1">331</td><td colspan="1" rowspan="1">1.00</td><td colspan="1" rowspan="1">0.43</td><td colspan="1" rowspan="1">0.9978</td><td colspan="1" rowspan="1">0.87</td></tr><tr><td colspan="1" rowspan="1">FO2Hb</td><td colspan="1" rowspan="1">%</td><td colspan="1" rowspan="1">3.7</td><td colspan="1" rowspan="1">98.5</td><td colspan="1" rowspan="1">446</td><td colspan="1" rowspan="1">1.00</td><td colspan="1" rowspan="1">0.30</td><td colspan="1" rowspan="1">0.9984</td><td colspan="1" rowspan="1">0.81</td></tr><tr><td colspan="1" rowspan="1">FCOHb</td><td colspan="1" rowspan="1">%</td><td colspan="1" rowspan="1">1.0</td><td colspan="1" rowspan="1">92.2</td><td colspan="1" rowspan="1">198</td><td colspan="1" rowspan="1">1.01</td><td colspan="1" rowspan="1">-0.48</td><td colspan="1" rowspan="1">0.9994</td><td colspan="1" rowspan="1">0.43</td></tr><tr><td colspan="1" rowspan="1">FMetHb</td><td colspan="1" rowspan="1">%</td><td colspan="1" rowspan="1">1.0</td><td colspan="1" rowspan="1">91.0</td><td colspan="1" rowspan="1">246</td><td colspan="1" rowspan="1">1.00</td><td colspan="1" rowspan="1">0.29</td><td colspan="1" rowspan="1">0.9984</td><td colspan="1" rowspan="1">0.63</td></tr><tr><td colspan="1" rowspan="1">FHbF</td><td colspan="1" rowspan="1">%</td><td colspan="1" rowspan="1">21</td><td colspan="1" rowspan="1">83</td><td colspan="1" rowspan="1">25</td><td colspan="1" rowspan="1">0.95</td><td colspan="1" rowspan="1">5.62</td><td colspan="1" rowspan="1">0.8298</td><td colspan="1" rowspan="1">8.17</td></tr></table>

b. Matrix comparison: Only matrix recommended for ABL90FLEX is heparinized whole blood.

3. Clinical studies:

a. Clinical Sensitivity: Not Applicable   
b. Clinical specificity: Not Applicable   
c. Other clinical supportive data (when a. and b. are not applicable): Not Applicable

4. Clinical cut-off: Not Applicable

5. Expected values/Reference range:

<table><tr><td colspan="1" rowspan="1">Parameter</td><td colspan="1" rowspan="1">Population</td><td colspan="1" rowspan="1">Reference range</td><td colspan="1" rowspan="1">Cited from</td></tr><tr><td colspan="1" rowspan="1">pH,</td><td colspan="1" rowspan="1">Children, adults</td><td colspan="1" rowspan="1">7.35-7.45</td><td colspan="1" rowspan="1">Tietz 2008</td></tr><tr><td colspan="1" rowspan="2">pCO2</td><td colspan="1" rowspan="1">Female</td><td colspan="1" rowspan="1">4.3-6.0 kPa</td><td colspan="1" rowspan="1">Tietz 2008</td></tr><tr><td colspan="1" rowspan="1">Male</td><td colspan="1" rowspan="1">4.7-6.4 kPa</td><td colspan="1" rowspan="1">Tietz 2008</td></tr><tr><td colspan="1" rowspan="1">pO2</td><td colspan="1" rowspan="1">2days- 60years</td><td colspan="1" rowspan="1">11.0-14.4 kPa</td><td colspan="1" rowspan="1">Tietz 2008</td></tr><tr><td colspan="1" rowspan="1">cK+</td><td colspan="1" rowspan="1">Male, female</td><td colspan="1" rowspan="1">3.4-4.5 meq/L</td><td colspan="1" rowspan="1">Tietz 19872</td></tr><tr><td colspan="1" rowspan="1">cNa+</td><td colspan="1" rowspan="1">Male, female</td><td colspan="1" rowspan="1">136-146 meq/L</td><td colspan="1" rowspan="1">Tietz 1987</td></tr><tr><td colspan="1" rowspan="1">cCa^{+$</td><td colspan="1" rowspan="1">Adult</td><td colspan="1" rowspan="1">2.30-2.66 meq/L</td><td colspan="1" rowspan="1">Tietz 2008</td></tr><tr><td colspan="1" rowspan="1">cCl</td><td colspan="1" rowspan="1">Adult</td><td colspan="1" rowspan="1">98-107 meq/L</td><td colspan="1" rowspan="1">Tietz 2008</td></tr><tr><td colspan="1" rowspan="1">cGlucose</td><td colspan="1" rowspan="1">Adult</td><td colspan="1" rowspan="1">65-95 mg/dL</td><td colspan="1" rowspan="1">Tietz 2008</td></tr><tr><td colspan="1" rowspan="2">cLactate</td><td colspan="1" rowspan="1">Female, male</td><td colspan="1" rowspan="1">4.5-14.4 mg/L</td><td colspan="1" rowspan="1">Tietz 1987</td></tr><tr><td colspan="1" rowspan="1">At bed rest</td><td colspan="1" rowspan="1">3.0-7.0 mg/L</td><td colspan="1" rowspan="1">Tietz 2008</td></tr><tr><td colspan="1" rowspan="2">ctHb</td><td colspan="1" rowspan="1">Female</td><td colspan="1" rowspan="1">12.0-16.0 g/dL</td><td colspan="1" rowspan="1">Tietz 1987</td></tr><tr><td colspan="1" rowspan="1">Male</td><td colspan="1" rowspan="1">13.5-17.5 g/dL</td><td colspan="1" rowspan="1">Tietz 1987</td></tr><tr><td colspan="1" rowspan="3">sO2</td><td colspan="1" rowspan="1">Male, female</td><td colspan="1" rowspan="1">95-99 %</td><td colspan="1" rowspan="1">Siggaard-Andersen et al3.</td></tr><tr><td colspan="1" rowspan="1">Infants, children,adults</td><td colspan="1" rowspan="1">94-98 %</td><td colspan="1" rowspan="1">Tietz 2008</td></tr><tr><td colspan="1" rowspan="1">Newborn</td><td colspan="1" rowspan="1">40-90 %</td><td colspan="1" rowspan="1">Tietz 2008</td></tr><tr><td colspan="1" rowspan="1">FO2Hb</td><td colspan="1" rowspan="1">Male, female</td><td colspan="1" rowspan="1">94-98 %</td><td colspan="1" rowspan="1">Tietz1987</td></tr><tr><td colspan="1" rowspan="1">FCOHb</td><td colspan="1" rowspan="1">Male, female</td><td colspan="1" rowspan="1">0.5-1.5 %</td><td colspan="1" rowspan="1">Tietz1987</td></tr><tr><td colspan="1" rowspan="1">FHHb</td><td colspan="1" rowspan="1">N/A</td><td colspan="1" rowspan="1">N/A</td><td colspan="1" rowspan="1">N/A</td></tr><tr><td colspan="1" rowspan="1">FMetHb</td><td colspan="1" rowspan="1">Male, female</td><td colspan="1" rowspan="1">0.0-1.5 %</td><td colspan="1" rowspan="1">Tietz 2008</td></tr><tr><td colspan="1" rowspan="1">FHbF</td><td colspan="1" rowspan="1">Neonates</td><td colspan="1" rowspan="1">≈ 80 %</td><td colspan="1" rowspan="1">Tietz 2008</td></tr></table>

N. Instrument Name: Radiometer ABL90 FLEX

# O. System Descriptions:

1. Modes of Operation: Single sample mode

2. Software:

FDA has reviewed applicant’s Hazard Analysis and software development processes for this line of product types:

Yes ___X____ or No

3. Specimen Identification: Single Sample

4. Specimen Sampling and Handling: This device is intended to be used with whole blood samples.

5. Calibration:

Two-Point liquid calibration. Calibration and QC reagents plus a waste reservoir are contained in one solution pack. "Smartchip "technology for unique

identification and lot specific calibration and quality control data

6. Quality Control:

QC reagents plus a waste reservoir are contained in one solution pack. "Smartchip "technology for unique identification and lot specific calibration and quality control data

P. Other Supportive Instrument Performance Characteristics Data Not Covered In The “Performance Characteristics” Section above: None

Q. Proposed Labeling: The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# R. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.